Ares Trading S.A. - Oct 12, 2021 Form 4 Insider Report for PRECIGEN, INC. (PGEN)

Role
10%+ Owner
Signature
/s/ Cedric Hyde, Authorized Signatory of Merck Serono SA
Stock symbol
PGEN
Transactions as of
Oct 12, 2021
Transactions value $
-$666,756
Form type
4
Date filed
10/14/2021, 06:02 PM
Previous filing
Oct 12, 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PGEN Common Stock Sale -$299K -63.9K -0.31% $4.69 20.7M Oct 12, 2021 Direct F1
transaction PGEN Common Stock Sale -$367K -79.9K -0.39% $4.60 20.6M Oct 13, 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Ares Trading S.A. is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Ares Trading, S.A. on April 29, 2021.The plan was terminated effective October 13, 2021.